MVIR Medivir AB (publ)
1.594SEK-5.46%Mkt Cap: 95.17M $P/E: —1d ago
Medivir AB (publ), a pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationall…
Industry Peers
Biotechnology$127.54BUSDP/E 29.3
$81.13BUSD
$74.79BUSDP/E 18.0
$57.11BUSDP/E 34.8
$55.24BUSDP/E 36.1
$44.51BUSD
$41.63BUSDP/E 17.7
$41.14BUSDP/E 64.7
$32.74BUSDP/E 30.1
$29.42BUSDP/E 37.1
$25.84BUSD
$24.53BUSD
$24.01BUSDP/E 30.3
$23.13BUSDP/E 14.5
$22.67BUSD
$21.61BUSDP/E 29.3
$15.32BUSDP/E 16.2
$15.01BUSDP/E 17.5
$14.58BUSDP/E 18.6
$13.78BUSD
| Headline | Source | Time |
|---|---|---|
Older | ||
Medivir AB (STU:MVR0) (Q2 2026) Earnings Call Highlights: Advancing Fostrox in HCC and MIV-711 ... Medivir AB (STU:MVR0) reports strong progress across its pipeline, with key data readouts expected in 2027 and a strengthened cash position to fund operations into 2030. | ||
DDagens Juridik | ||